Roundhill GLP-1 & Weight Loss ETF
OZEM
#2772
ETF rank
ยฃ42.36 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
ยฃ25.37
Share price
-0.94%
Change (1 day)
24.39%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of February 23, 2026Number of holdings: 26

Full holdings list

Weight %NameTickerShares Held
17.79%
Novo Nordisk A/SNVO220680
14.57%
Eli Lilly & CoLLY8494
5.07%
Ascletis Pharma Inc1672 HK1319000
4.68%
Chugai Pharmaceutical Co Ltd4519 JP42900
4.65%
Roche Holding AGROG SW5764
4.46%
Hanmi Pharm Co Ltd128940 KS6223
4.14%
Pfizer IncPFE91429
3.96%
Amgen IncAMGN6224
3.77%
Structure Therapeutics IncGPCR33344
3.76%
Viking Therapeutics IncVKTX71364
3.72%
Zealand Pharma A/SZEAL DC35303
3.61%
Innovent Biologics Inc1801 HK183000
3.43%
AstraZeneca PLCAZN9894
3.17%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK726000
2.77%
Regeneron Pharmaceuticals IncREGN2088
2.32%
CSPC Pharmaceutical Group Ltd1093 HK1016000
2.25%
Gilead Sciences IncGILD8763
2.09%
United Laboratories International Holdings Ltd/The3933 HK778000
2.04%
Scholar Rock Holding CorpSRRK24964
1.83%
Gubra A/SGUBRA DC18205
1.74%
Shionogi & Co Ltd4507 JP43600
1.71%
Biohaven LtdBHVN89380
1.32%
Rhythm Pharmaceuticals IncRYTM7782
0.75%
WaVe Life Sciences LtdWVE32904
0.26%
Cash & OtherCash&Other152435.19
0.12%
First American Government Obligations Fund 12/01/2031FGXXX73164.95